At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 72 enrolled
Drug / intervention
Contact Lenses with 8.5 BC +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of 8.5 vs 9.0 Base Curve for 1-DAY ACUVUE(r) TruEye(r) Brand Contact Lenses
In Brief
A Phase 4 clinical trial evaluating Contact Lenses with 8.5 BC and Contact Lenses with 9.0 BC for Contact Lens Base Curve (BC) Fit and Comfort. Completed, enrolled 72 participants across 2 sites.
Detailed Summary
The objective of this study is to determine if corneal diameter and keratometry readings correlate to subjective comfort and lens fitting characteristics.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
Primary CompletionJul 2015
First PostedSep 2015
TodayJul 2026
First PostedSep 1, 2015
Enrollment StartJul 1, 2015
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 10.8 years ago
Interventions
Contact Lenses with 8.5 BCdevice
Subjects will wear the marketed, daily disposable contact lenses in 8.5 BC.
Contact Lenses with 9.0 BCdevice
Subjects will wear the marketed, daily disposable contact lenses in 9.0 BC.